Evidence map›Paper›PMID 36559043›Full record

ArticlePharmaceutics2022

Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus.

Anna-Liisa Kubo, Kai Rausalu, Natalja Savest, Eva Žusinaite, Grigory Vasiliev, Mihkel Viirsalu, Tiia Plamus, Andres Krumme, Andres Merits, Olesja Bondarenko

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. SyntheticRSC advances · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna-Liisa KuboLaboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia.ORCID 0000-0003-2026-5340
Kai RausaluInstitute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.
Natalja SavestLaboratory of Polymers and Textile Technology, Department of Materials and Environmental Technology, Tallinn University of Technology, Ehitajate tee 5, 19086 Tallinn, Estonia.
Eva ŽusinaiteInstitute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.
Grigory VasilievLaboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia.ORCID 0000-0002-2608-536X
Mihkel ViirsaluLaboratory of Polymers and Textile Technology, Department of Materials and Environmental Technology, Tallinn University of Technology, Ehitajate tee 5, 19086 Tallinn, Estonia.
Tiia PlamusLaboratory of Polymers and Textile Technology, Department of Materials and Environmental Technology, Tallinn University of Technology, Ehitajate tee 5, 19086 Tallinn, Estonia.ORCID 0000-0002-3407-9461
Andres KrummeLaboratory of Polymers and Textile Technology, Department of Materials and Environmental Technology, Tallinn University of Technology, Ehitajate tee 5, 19086 Tallinn, Estonia.ORCID 0000-0003-4180-1990
Andres MeritsInstitute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.ORCID 0000-0001-8193-0071
Olesja BondarenkoLaboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618 Tallinn, Estonia.ORCID 0000-0001-8767-1365

Funding

Estonian Research Council COVSG16European Regional Development Fund TK134National Institute of Chemical Physics and Biophysics Development Grant Arengufond_OB
6 · The paper itself

Abstract

Due to the high prevalence of infectious diseases and their concurrent outbreaks, there is a high interest in developing novel materials with antimicrobial properties. Antibacterial and antiviral properties of a range of metal-based nanoparticles (NPs) are a promising means to fight airborne diseases caused by viruses and bacteria. The aim of this study was to test antimicrobial metals and metal-based nanoparticles efficacy against three viruses, namely influenza A virus (H1N1; A/WSN/1933) and coronaviruses TGEV and SARS-CoV-2; and two bacteria,

Indexed as

copper oxidecoronaviruselectrospinningface maskssilvertoxicityzinc oxide

Identifiers

PMID36559043
PMCPMC9785359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.